IP Library › Granted Patent US 6,987,178
Granted Patent B2
US 6,987,178 · App. 10/165,813 · Granted Jan 17, 2006

Human uncoupling proteins and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,987,178
App. No.
10/165,813
Granted
Jan 17, 2006
Kind
B2
Abstract

The present invention relates to methods and compositions for the treatment of biological disorders regulatable by the controlled expression or inhibition of the described uncoupling proteins (UCPs).

Claims (6)

1. A recombinant expression vector comprising an isolated nucleic acid molecule that encodes the amino acid sequence of SEQ ID NO:2.

2. The recombinant expression vector of claim 1 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:1.

3. A host cell comprising the vector of claim 1 .

4. A recombinant expression vector comprising an isolated nucleic acid molecule that encodes the amino acid sequence of SEQ ID NO:4.

5. The recombinant expression vector of claim 4 , wherein said isolated nucleic acid molecule comprises the nucleic acid sequence of SEQ ID NO:3.

6. A host cell comprising the vector of claim 4 .

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →